Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis - Øivind Torkildsen; Hilde Kjelgaard Brustad; Einar August Høgestøl; Karl Bjørnar Alstadhaug; Alok Bhan; Heidi Øyen Flemmen; Andrea Habbestad; Rune A.A. Høglund; Marissa LeBlanc; Peter Lopen; Åslaug Rudjord Lorentzen; Åse Hagen Morsund; et al. (New England Journal of Medicine, 2026)